(Q41750853)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561814%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

review article

1 reference

title

Antibiotic resistance problems in the critical care unit (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561814%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

main subject

antibiotic resistance

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561814%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

J Carlet

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561814%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J Acar

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561814%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 April 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561814%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

published in

Critical Care Clinics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561814%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561814%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561814%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

199-219

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561814%20AND%20SRC:MED&resulttype=core&format=json

American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Nosocomial Legionnaires' Disease Caused by Aerosolized Tap Water from Respiratory Devices

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Pneumococcal resistance to beta-lactam antibiotics: a global geographic overview

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Additional DNA in methicillin-resistant Staphylococcus aureus and molecular cloning of mec-specific DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Identification and biotyping of clinical isolates of Acinetobacter

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

A functional classification scheme for beta-lactamases and its correlation with molecular structure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Ciprofloxacin resistance among nosocomial Pseudomonas aeruginosa and Staphylococcus aureus in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Antibiotic treatment of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Selective digestive decontamination by erythromycin-base in a polyvalent intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Management of infections caused by antibiotic-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Secondary carriage with multi-resistant Acinetobacter baumannii and Klebsiella pneumoniae in an adult ICU population: relationship with nosocomial infections and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Characterization of ceftriaxone-resistant Enterobacteriaceae: a multicentre study in 26 French hospitals. Vigil'Roc Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-93 western Europe and USA collaborative surveillance study. The Alexander Project Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

More extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study)

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Resistance to antimicrobial drugs--a worldwide calamity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Hospital-acquired Infection with Vancomycin-resistant Enterococcus faecium Transmitted by Electronic Thermometers

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Minimizing antimicrobial resistance in hospital bacteria: can switching or cycling drugs help?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Xanthomonas maltophilia: an emerging nosocomial pathogen

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Nosocomial legionellosis associated with use of oxygen bubble humidifiers and underwater chest drains

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Methicillin-resistant Staphylococcus aureus as a community organism

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Beta-lactamase-producing enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

ARI 1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Antibiotic resistance of clinical isolates of Enterococcus in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Treatment of severe staphylococcal infections with cefotaxime and fosfomycin in combination

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Major trends in the microbial etiology of nosocomial infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Decreased transmission of Enterobacteriaceae with extended-spectrum beta-lactamases in an intensive care unit by nursing reorganization

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Selective decontamination of the digestive tract (SDD) in intensive care patients: a critical evaluation of the clinical, bacteriological and epidemiological benefits

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Clinical isolates of Escherichia coli producing TRI beta-lactamases: novel TEM-enzymes conferring resistance to beta-lactamase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Methicillin-resistant Staphylococcus aureus in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Transferable imipenem resistance in Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Stool Carriage, Clinical Isolation, and Mortality During an Outbreak of Vancomycin-Resistant Enterococci in Hospitalized Medical and/or Surgical Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Biochemical characterization of a beta-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970392-4

7 January 2021

10.1016/S0749-0704(05)70392-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561814%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference